MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/rmdopen-2025-005724

Медицинская библиотека · RMD open · 2025

TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.

Kummer Laura Yl, Kuijper Lisan H, Fernández Blanco Laura, Bos Amélie, Kreher Christine, Verstegen Niels Jm, Duurland Mariël C, Konijn Veronique Al, Jorritsma Tineke, Tempert Maryse, Menage Charlotte, Steenhuis Maurice, van Gils Marit J, Claireaux Mathieu, Garcia-Vallejo Juan J, D'Haens Geert Ram, Löwenberg Mark, Volkers Adriaan G, van Dam Koos Pj, Stalman Eileen W, Wieske Luuk, Tas Sander W, Boekel Laura, Wolbink Gertjan, Rispens Theo, Kuijpers Taco W, Eftimov Filip, van Ham S Marieke, Ten Brinke Anja

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Tumour necrosis factor inhibitors (TNFi) are widely used and effective as treatment for immune-mediated inflammatory diseases (IMIDs). However, TNFi therapy causes a faster waning of antibody responses following vaccination. The underlying cause by which TNFi affect humoral immunity remains to be elucidated. The formation of long-lasting, high-affinity antibodies after vaccination results from germinal centre (GC)-derived, T cell-dependent B-cell responses. Therefore, this study investigated how TNFi affect the formation and maintenance of antigen-specific B- and CD4+ T-cell responses following SARS-CoV-2 mRNA vaccination.

METHODS

SARS-CoV-2 spike-specific B-cell responses were characterised using spectral flow cytometry. Spike-specific CD4+ T cells were measured using an activation-induced marker assay. 15 patients with inflammatory bowel disease (IBD) treated with TNFi were compared with 9 IBD patients without systemic immunosuppression and 10 healthy controls.

RESULTS

Spike-specific CD4+T-cell frequency and phenotype, including T follicular helper cells, were not affected by TNFi. Total spike-specific B-cell frequencies were reduced in TNFi-treated patients. Deep phenotyping revealed lower IgG+memory B-cell frequencies in TNFi-treated patients 3-6 months after vaccination. These data were confirmed in TNFi-treated rheumatoid arthritis patients. Interestingly, already at day 7 after the second vaccination, TNFi therapy reduced the induction of class-switched CD11c- CD71+activated B cells, which are believed to be GC-derived. Conversely, CD11c+B cells, associated with extrafollicular B-cell responses, were not affected by TNFi therapy.

CONCLUSIONS

These data suggest that TNFi therapy affects the differentiation of GC-derived B cells, which may explain its effect on humoral immune responses.

Для цитирования: Kummer Laura Yl, Kuijper Lisan H, Fernández Blanco Laura, Bos Amélie, Kreher Christine, Verstegen Niels Jm, Duurland Mariël C, Konijn Veronique Al, Jorritsma Tineke, Tempert Maryse, Menage Charlotte, Steenhuis Maurice, van Gils Marit J, Claireaux Mathieu, Garcia-Vallejo Juan J, D'Haens Geert Ram, Löwenberg Mark, Volkers Adriaan G, van Dam Koos Pj, Stalman Eileen W, Wieske Luuk, Tas Sander W, Boekel Laura, Wolbink Gertjan, Rispens Theo, Kuijpers Taco W, Eftimov Filip, van Ham S Marieke, Ten Brinke Anja. TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination.. RMD open. 2025. DOI: 10.1136/rmdopen-2025-005724.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.